Cancer Testing Market- Market Status, Growth and Trends by 2018

1
Cancer Test Market Forecast, Companies Cancer
Test Platform, Pipeline Analysis and Clinical
Trials - Global
No. of Pages 277
Published Date October 2013
Price Single User US1590
Corporate User US2300
2
New Market Research Report on Cancer Test Market
Forecast, Companies Cancer Test Platform,
Pipeline Analysis and Clinical Trials - Global
added to ReportsnReports.com
The UK is among one of the fattest countries in
the EU. In 2010 an estimated 63 of people aged
16 or over in England and 57 in Wales were
classified as overweight or obese. In Scotland
63.3 of adults aged 16 to 64 were in that
category. While the proportion of overweight
people has not changed significantly, the
proportion of obese people has increased by 11
percentage points since 1993. Overweight and
obesity are steadily spreading in both the adult
3
Cancer Test Market Forecast, Companies Cancer
Test Platform, Pipeline Analysis and Clinical
Trials - Global
and the child populations across the UK. The
available data and reports on obesity in the UK
paint quite a worrying picture of the progression
of the obesity epidemic in the UK population over
the coming decades. As the WHO warns of the many
impacts of a global obesity epidemic, the UK is
faced with difficult choices to tackle its own
obesity problem and avert a future where 60 of
men and 50 of women are obese.
Browse more research reports on Pharmaceuticals _at_
http//www.reportsnreports.com/market-research/pha
rmaceuticals/ .
4
Cancer Test Market Forecast, Companies Cancer
Test Platform, Pipeline Analysis and Clinical
Trials - Global
The direct and indirect costs of obesity are
high. Across the UK, the estimated direct costs
to the NHS of treating overweight and obesity as
well as obesity-related illnesses jumped from
479.3m in 1998 to 4.2bn in 2007. The estimated
indirect costs of obesity to the UK economy were
valued at anywhere between 2.6bn and 15.8bn per
year in 2007. The NHS now spends an estimated
50m to 85m per year on bariatric surgery.
NHS-funded bariatric procedures in England jumped
from 261 in 2000/01 to 8,087 in 2010/11 while
10,831,705 prescription items for drugs for the
treatment of obesity were
Buy a copy of this report _at_ http//www.reportsnrep
orts.com/purchase.aspx?name276963 .
5
Cancer Test Market Forecast, Companies Cancer
Test Platform, Pipeline Analysis and Clinical
Trials - Global
dispensed in England alone between 1999 and 2011,
amounting to nearly 420.5m. Surgical and
pharmaceutical interventions are now restricted
by artificial caps put on referrals and the lack
of choice of prescription obesity drugs available
apart from Orlistat. However, costs overall will
increase as the proportion of obese people
increases. For Complete Detail Follow Below
Link
Complete Report _at_ http//www.reportsnreports.com/r
eports/276963-cancer-test-market-forecast-companie
s-cancer-test-platform-pipeline-analysis-and-clini
cal-trials-global.html .
6
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.